SGP
SpyGlass Pharma, Inc.
26.00$
-4.0%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
SpyGlass Pharma, Inc. (SGP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| -12 | -22 | -33 | |
| 0.1 | 0.3 | 0.6 | |
| 0.9 | 1.5 | 2.8 | |
| 0.1 | 1.3 | 2.4 | |
| 0.2 | 2.0 | 0.8 | |
| – | – | -12 | |
| – | 0.0 | -1.5 | |
| 40 | 0.2 | 125 | |
| 7.0 | 0.4 | 80 | |
| -12 | -24 | -33 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.